CLINICAL RESEARCH & DIAGNOSTICS Clinical Trials Update news from GENLatest news on the progress of drug candidates through the different phases of clinical trials. Thursday, March 13, 2008http://www.genengnews.com/news/newslist.aspx?taxid=26 Teva Provides Update on Glatiramer Acetate 40mg for Amyotrophic Lateral Sclerosis (ALS) Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=32007672 Nitric BioTherapeutics Launches Phase II Clinical Trial for the Use of Nitric Oxide in the Healing of Chronic Wounds Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=32006848 Novelos Therapeutics Reaches Target Enrollment in Pivotal Phase 3 Lung Cancer Trial Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=32003406 ArQule Enrolls First Patient in Phase 1/2 Clinical Trial Program of ARQ 197 in Non-Small Cell Lung Cancer Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=32003486 Neoprobe Presents Final Phase 2 Lymphoseek Results Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=32003496 Vertex Pharmaceuticals and Tibotec Announce Start of Phase 3 'ADVANCE' Study with Telaprevir in Treatment-Naive, Genotype 1 HCV Patients Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=32002700 Calando Files IND for siRNA Nanoparticle Therapeutic in Oncology Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31997828 Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=32002924 Arrowhead Subsidiary, Calando Pharmaceuticals, Submits IND for Clinical Trial with Targeted, Nano-Delivered RNAi Therapeutic for Cancer Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31991316 Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease Thursday, March 13, 2008 http://www.genengnews.com/news/bnitem.aspx?name=32000471 Allovectin-7(R) May Offer Patients a New Option for Advanced Melanoma Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31964689 HealthSonix to Conduct Clinical Trials with ZingiberRx for Complex Regional Pain Syndrome (CRPS) Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31947288 Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31946500 XenoPort Announces Positive Results of a Phase 1 Clinical Trial of XP21279 Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31944899 Celsion Commences Global Phase III Study for Primary Liver Cancer Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31944076 Urigen Announces Positive Phase II Clinical Trial Results with URG101 Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31944108 Unigene Successfully Completes Phase I/II Clinical Study for Oral Calcitonin Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31944079 Avexa Reports Superior Results in ATC Phase IIb Clinical Trial Update Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31943306 CombinatoRx Drug Candidate CRx-191 Demonstrates Positive Phase 2 Results in Psoriasis Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31940942 Anti-Cancer Drug CYT997 Update Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31979231 AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC) Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31945911 Wyeth and Progenics Provide Update on Phase 3 Clinical Trial of Intravenous Methylnaltrexone for Postoperative Ileus Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31936298 Avicena's HD-02 to Proceed to NIH Sponsored Phase III Huntington's Disease Trial Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31944306 FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE Wednesday, March 12, 2008 http://www.genengnews.com/news/bnitem.aspx?name=31941937